2-Bromodeschloroketamine

2-Bromodeschloroketamine is a research chemical that belongs to the dissociative class of psychoactive drugs. It is an analog of ketamine in which the chlorine atom has been replaced by bromine.

Chemistry[edit | edit source]

2-Bromodeschloroketamine, also known as 2-Br-DCK, is a chiral molecule and is often produced as a racemate. It's a member of the arylcyclohexylamine class of substances. The structure of 2-Bromodeschloroketamine includes a phenyl ring bonded to a cyclohexane ring. An amino methyl chain (-N-CH3) is bonded to the same carbon of the cyclohexane ring as the bromine group.

Pharmacology[edit | edit source]

The pharmacological effects of 2-Bromodeschloroketamine are not fully understood. As an analog of ketamine, it is thought to function as an NMDA receptor antagonist. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open. Dissociatives like 2-Bromodeschloroketamine are believed to block the NMDA receptors, preventing these signals from occurring.

Effects[edit | edit source]

The effects of 2-Bromodeschloroketamine are similar to those of other dissociative anesthetics such as ketamine and PCP. These effects can include analgesia, amnesia, delirium, and hallucinations. However, the potency and toxicity of 2-Bromodeschloroketamine are not well-studied, and it is potentially dangerous to use this substance outside of a controlled laboratory setting.

Legal Status[edit | edit source]

The legal status of 2-Bromodeschloroketamine varies by country. It is not controlled in most countries, but it may be considered an analog of ketamine, which could make its sale or possession illegal under certain drug analog laws.